Deal · Completed
Cellution Biologics Inc. and Assets sold by Elutia Inc.
First filed 21 Aug 2026, 1 filing.
The deal
- Buyer
- Cellution Biologics Inc.
- Target
- Assets sold by Elutia Inc.
- Seller
- Elutia Inc.
- Status
- Completed
- Region
- US
Closing of Sale of SimpliDerm Business As previously reported, on July 16, 2026, Elutia Inc., a Delaware corporation (the " Company " or " Elutia ") executed an Asset Purchase Agreement (the " Purchase Agreement ") with Cellution Biologics Inc., a Delaware corporation (" Cellution Biologics ").
Source: The filing (SEC Form 8-K)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.